We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

87 hedge funds and large institutions have $141M invested in ChemoCentryx, Inc. in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $165K | Put options by funds: $78K

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

1% more funds holding

Funds holding: 86 → 87 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less capital invested

Capital invested by funds: $177M → $141M (-$36.1M)

Holders
87
Holders Change
+1
Holders Change %
+1.16%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
31
Reduced
25
Closed
6
Calls
$165K
Puts
$78K
Net Calls
+$87K
Net Calls Change
-$114K

Top Buyers

1
NCM
Nantahala Capital Management
Connecticut
+$1.83M
2
UC
Unterberg Capital
New York
+$686K
3
Morgan Stanley
Morgan Stanley
New York
+$400K
4
SCM
Sio Capital Management
New York
+$400K
5
Goldman Sachs
Goldman Sachs
New York
+$320K

Top Sellers

1
IHM
Iguana Healthcare Management
New York
-$1.2M
2
Deutsche Bank
Deutsche Bank
Germany
-$880K
3
ZIM
Zacks Investment Management
Illinois
-$589K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$583K
5
ADEF
Adams Diversified Equity Fund
Maryland
-$533K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$543K +$234K +34,140 +60%
Los Angeles Capital Management
27
Los Angeles Capital Management
California
$540K +$239K +34,904 +63%
SO
28
STRS Ohio
Ohio
$511K – – –
BTS
29
BB&T Securities
Virginia
$496K – – –
SCM
30
Sio Capital Management
New York
$496K +$400K +58,246 +231%
Invesco
31
Invesco
Georgia
$462K -$261K -38,102 -33%
CAM
32
ClariVest Asset Management
California
$458K +$186K +27,100 +54%
Ohio Public Employees Retirement System (OPERS)
33
Ohio Public Employees Retirement System (OPERS)
Ohio
$414K – – –
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$384K -$8.75K -1,276 -2%
Federated Hermes
35
Federated Hermes
Pennsylvania
$384K – – –
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$374K – – –
Citadel Advisors
37
Citadel Advisors
Florida
$340K +$73.7K +10,744 +23%
BPC
38
Banque Pictet & Cie
Switzerland
$322K – – –
BCM
39
Bridgeway Capital Management
Texas
$312K -$4.46K -650 -1%
BBA
40
Baker Bros. Advisors
New York
$292K – – –
Wells Fargo
41
Wells Fargo
California
$290K +$97K +14,133 +41%
TA
42
Teachers Advisors
New York
$273K +$27.7K +4,044 +10%
Russell Investments Group
43
Russell Investments Group
United Kingdom
$244K -$251K -36,546 -47%
KeyBank National Association
44
KeyBank National Association
Ohio
$241K – – –
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$232K +$5.96K +869 +2%
TI
46
Trexquant Investment
Connecticut
$230K +$265K +38,585 New
AllianceBernstein
47
AllianceBernstein
Tennessee
$223K – – –
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$221K -$38.9K -5,664 -13%
Charles Schwab
49
Charles Schwab
California
$210K – – –
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
$207K -$583K -84,913 -71%
1
2
3 4

CCXI Hedge Fund Activity: Q4 2017 in Review

87 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2017, worth a combined $141M — down 20% from $177M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CCXI positions and 6 closed out — a net gain of 1 holder — while 31 added to existing stakes and 25 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $1.83M. The largest seller was Iguana Healthcare Management, cutting an estimated $1.2M.

  • 87 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2017, up from 86 in Q3 2017.
  • Funds reported $141M of ChemoCentryx, Inc. stock for Q4 2017, down 20% quarter-over-quarter.
  • 7 funds opened new ChemoCentryx, Inc. positions in Q4 2017 and 6 closed out, a net change of +1 holder.
  • The largest ChemoCentryx, Inc. buyer in Q4 2017 was Nantahala Capital Management, an estimated $1.83M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2017 was Iguana Healthcare Management, an estimated $1.2M sold.

Based on aggregated 13F filings for Q4 2017.